Machine Learning Frameworks to Predict Neoadjuvant Chemotherapy Response in Breast Cancer Using Clinical and Pathological Features

Abstract

Modeling performances varied between standard versus ML classification methods. RF ML classifiers demonstrated the best predictive performance among all models.